10-bagger stocks are hard to spot. Over the past years, there have been several 10 and 100-baggers that are still maintaining their gains. Using InvestingPro tools, let's try and...
S&P 500 blended EPS growth for Q4 increases for the first time in 3 weeks, now expected to come in at -4.9% Peak earnings season rolls on this week with 1,276 global companies...
Biogen stock is getting favorable ratings after successful trial results for its latest Alzheimer's treatment Lecanemab is Biogen's latest attempt to cure the disease after its...
Let's be frank: The third quarter was a mess for stocks. It doesn't much matter where the stocks were traded, except this: U.S. stocks in September were not a place you wanted to...
Well, let’s just take a moment today and say one final goodbye to September. Here’s your hat, and there’s the door. The past month saw stocks on a downward tear...
EU attempting to revive Iran nuclear deal with market staying pessimistic Crude prices could rebound from oversold conditions but stay off 2022 highs Both Iran, US likely looking...
Biotechnology stocks represent companies that research, develop or market healthcare-related therapies or products. They typically use living organisms, biological systems, or...
US corporate share buybacks are on the rise. A company typically returns profits to shareholders in one of two ways—either via a dividend payout or a share buyback. Typically...
A strong performance from the mining, energy, consumer and healthcare sectors ensured the FTSE 100 outperformed today. Europe The DAX and CAC 40 are in the red, but both markets...